1-3 of 3
Mark A. Guthridge
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 5283: Elucidating a novel role for inositol polyphosphate 4-phosphatase type II (INPP4B) in mediating chemoresistance in acute myeloid leukemia

Sewa Rijal, Nhu-Y Nugyen, Tse-Chieh Teh, Natalie K. Rynkiewicz, Nik Cummings, Lisa Ooms, Sharon Avery, Julie Mcmanus, Mark A. Guthridge, Catriona Mclean, Christina A. Mitchell*, Andrew Wei*
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 5283.
https://doi.org/10.1158/1538-7445.AM2014-5283
Published: 01 October 2014
View article titled, Abstract 5283: Elucidating a novel role for inositol polyphosphate 4-phosphatase type II (INPP4B) in mediating chemoresistance in acute myeloid leukemia
Journal Articles

Abstract A19: The selective targeting of cell survival pathways in leukemia

Daniel Thomas, Jason A. Powell, Michael W. Parker, Paul G. Ekert, Richard B. Lock, David CS Huang, Susie K. Nilsson, Christian Recher, Andrew H. Wei, Mark A. Guthridge
Journal: Cancer Research
Cancer Res (2013) 73 (19_Supplement): A19.
https://doi.org/10.1158/1538-7445.FBCR13-A19
Published: 15 May 2014
View article titled, Abstract A19: The selective targeting of cell survival pathways in leukemia
Journal Articles

Essential Requirement for PP2A Inhibition by the Oncogenic Receptor c-KIT Suggests PP2A Reactivation as a Strategy to Treat c-KIT+ Cancers

Kathryn G. Roberts, Amanda M. Smith, Fiona McDougall, Helen Carpenter, Martin Horan, Paolo Neviani, Jason A. Powell, Daniel Thomas, Mark A. Guthridge, Danilo Perrotti, Alistair T.R. Sim, Leonie K. Ashman, Nicole M. Verrills
Journal: Cancer Research
Cancer Res (2010) 70 (13): 5438–5447.
https://doi.org/10.1158/0008-5472.CAN-09-2544
Published: 30 June 2010
View article titled, Essential Requirement for PP2A Inhibition by the Oncogenic Receptor c-KIT Suggests PP2A Reactivation as a Strategy to Treat c-KIT<sup>+</sup> Cancers
Open the PDF for Essential Requirement for PP2A Inhibition by the Oncogenic Receptor c-KIT Suggests PP2A Reactivation as a Strategy to Treat c-KIT<sup>+</sup> Cancers in another window
Includes: Supplementary data